Midwall fibrosis: Cardiac magnetic resonance imaging in risk stratifying cardiomyopathies

D. P. Ripley, P. Garg, A. Kotecha, O. E. Gosling, N. G. Bellenger

Research output: Contribution to journalArticlepeer-review


The United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM.

Original languageEnglish
Article numberA1
Pages (from-to)89-90
Number of pages2
JournalOpen Cardiovascular Medicine Journal
Publication statusPublished - 2015


  • Dilated Cardiomyopathy
  • Fibrosis
  • Magnetic Resonance Imaging
  • Sudden Cardiac Death
  • Ventricular Tachycardia

Cite this